Dienogest is a selective progesterone receptor agonist in transactivation analysis with potent oral endometrial activity due to its efficient pharmacokinetic profile
article
OA: closed
CC0
⤵ 127 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (60)
- Advances in the management of endometriosis: an update for clinicians via openalex
- Animal studies on the endocrinological profile of dienogest, a novel synthetic steroid. via openalex
- Carbohydrate Metabolism during Treatment of Endometriosis with the Progestin Dienogest <sup>*</sup>) via openalex
- Current place of progestins in the treatment of endometriosis-related complaints via openalex
- Danazol and gestagen displacement of testosterone and influence on sex-hormone-binding globulin capacity via openalex
- Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study via openalex
- DOSAGE‐RELATED EFFECTS OF DANAZOL ON SEX HORMONE BINDING GLOBULIN AND FREE AND TOTAL ANDROGEN LEVELS via openalex
- Effects of danazol on plasma lipid and lipoprotein levels in healthy women and in women with endometriosis via openalex
- Effects of progesterone, progestogens, and danazol on the specific cortisol binding in human plasma via openalex
- Free testosterone levels during danazol therapy via openalex
- High-dose pilot study with the novel progestogen dienogestin patients with endometriosis via openalex
- Lipoprotein changes during treatment of pelvic endometriosis with medroxyprogesterone acetate via openalex
- Lipoprotein changes during treatment of pelvic endometriosis with medroxyprogesterone acetate. via openalex
- Newer progestogens via openalex
- New Progestogens via openalex
- Pharmacokinetics of the Progestin Dienogest (STS 557) in Rabbits<sup>*</sup>) via openalex
- Pharmacological profile of progestins via openalex
- Plasma lipoproteins during and after danazol treatment via openalex
- The role of antiandrogens in hormone replacement therapy. via openalex
- doi:10.1016/0039-128x(79)90090-4 via openalex
- doi:10.1055/s-0029-1210229 via openalex
- W2398186779 via openalex
- W2405601268 via openalex
- W2424259334 via openalex
- W2497131907 via openalex
- W2511156109 via openalex
- W4285719527 via openalex
- W6602461298 via openalex
- W6607144580 via openalex
- W6712549599 via openalex
- W6717668247 via openalex
- W6723391054 via openalex
- W6725219575 via openalex
- doi:10.1210/en.142.9.3791 via openalex
- doi:10.1016/s0378-4347(00)86126-5 via openalex
- doi:10.1210/me.14.6.889 via openalex
- doi:10.1016/s0006-291x(02)00564-8 via openalex
- doi:10.1074/jbc.m107844200 via openalex
- doi:10.1002/j.1460-2075.1989.tb03604.x via openalex
- doi:10.1038/325075a0 via openalex
- doi:10.1002/j.1460-2075.1990.tb08280.x via openalex
- doi:10.1007/bf02627727 via openalex
- W171184433 via openalex
- doi:10.1210/endo.142.9.8401 via openalex
- doi:10.1016/s0002-9343(99)80067-9 via openalex
- doi:10.1016/0022-4731(81)90319-8 via openalex
- doi:10.1016/0002-9378(93)90335-g via openalex
- doi:10.1016/0010-7824(85)90074-5 via openalex
- doi:10.1074/jbc.m000042200 via openalex
- doi:10.1016/j.mce.2003.10.030 via openalex
- doi:10.1016/0092-8674(87)90581-2 via openalex
- doi:10.1007/s001980200080 via openalex
- doi:10.1016/0010-7824(80)90140-7 via openalex
- doi:10.1016/j.maturitas.2003.09.014 via openalex
- doi:10.1161/hc4801.099737 via openalex
- doi:10.1113/jphysiol.1934.sp003217 via openalex
- doi:10.1093/nar/30.6.1387 via openalex
- doi:10.1093/nar/13.23.8293 via openalex
- doi:10.1210/mend.14.6.0467 via openalex
- doi:10.1128/mcb.22.11.3698-3706.2002 via openalex
Cited by (50)
- Long-term clinical outcomes of dienogest for perimenopausal women with symptomatic adenomyosis 2025
- High inhibition ratio and transformation index of 2 mg dienogest: further evidence for its use in endometriosis treatment 2025
- NLRP3 concentration, oxidants, and antioxidants in plasma of endometriosis patients undergoing treatment with dienogest 2024
- The effects of dienogest and combined oral contraceptives on protein S-specific activity in endometriosis patients 2024
- Dienogest in conjunction with GnRH-a for postoperative management of endometriosis 2024
- The use of dienogest in treatment of symptomatic adenomyosis: A systematic review and meta-analysis 2024
- Azurocidin is associated with dienogest-resistance in ovarian endometriotic cysts 2024
- Analysis of a clinical case of managing a patient with intraoperative bladder injury 2024
- Additional file 4 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 5 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- A Bioequivalence Trial of Dienogest in Healthy Chinese Participants Under Fed Conditions 2023
- Efficacy and Safety of Dienogest in the Management of Women with Endometriosis; Systematic Review and Meta-Analysis 2023
- Additional file 2 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 10 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Efficacy and safety of different subsequent therapies after fertility preserving surgery for endometriosis: A systematic review and network meta-analysis 2023
- Efficacy of Dienogest on Pelvic Pain and Dyspareunia: Comprehensive Meta-Analysis and Systematic Review 2023
- Additional file 7 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 2 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 10 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 8 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 5 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 8 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Dienogest versus norethisterone acetate in management of endometrial hyperplasia without atypia 2023
- Additional file 1 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 4 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 7 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 9 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Risk factors of heavy uterine bleeding in patients with endometriosis and adenomyosis treated with dienogest 2023
- Additional file 1 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 6 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 3 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 3 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 9 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Additional file 6 of Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis 2023
- Adenosine deaminase family acting on RNA 1 may be a de novo target on endometriosis 2023
- Dienogest May Reduce Estradiol- and Inflammatory Cytokine-Induced Cell Viability and Proliferation and Inhibit the Pathogenesis of Endometriosis: A Cell Culture- and Mouse Model-Based Study 2022
- Androgen Signaling in Uterine Diseases: New Insights and New Targets 2022
- Maintenance dienogest therapy following adjuvant gonadotropin‐releasing hormone agonist treatment after uterus‐sparing surgery in adenomyosis: A retrospective cohort study 2022
- Long-term treatment of dienogest with symptomatic adenomyosis: retrospective analysis of efficacy and safety in clinical practice 2022
- Prediction of the final menstrual period in women taking Dienogest using estradiol and follicle-stimulating hormone values: a case-control study 2022
- Determination of the number of women with endometriosis in private medical offices in the county of Cruz Alta – RS / Determinação do número de mulheres com endometriose em consultórios médicos particulares no munícipio de Cruz Alta-RS / 2022
- Roles of Two Small Leucine-Rich Proteoglycans Decorin and Biglycan in Pregnancy and Pregnancy-Associated Diseases. 2021
- Role of estrogen and estrogen-related factors in endometriosis 2021
- Adenomyosis: clinical aspects, impact on fertility and pregnancy outcome 2020
- A multicenter, randomized, placebo-controlled, double-blind, comparative study of dienogest at 1 mg/day in patients with primary and secondary dysmenorrhea 2020
- Long‐term use of dienogest for the treatment of primary and secondary dysmenorrhea 2020
- Safety and Effectiveness of Dienogest (Visanne®) for Treatment of Endometriosis: A Large Prospective Cohort Study 2020
- New treatment strategy for endometriosis using progestin-primed ovarian stimulation with dienogest: A prospective cohort study, comparison of dienogest versus dydrogesterone 2020
- Role of Hormones in Common Benign Uterine Lesions: Endometrial Polyps, Leiomyomas, and Adenomyosis 2020
Source provenance
- openalex
- last seen: 2026-05-11T05:37:28.352103+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK